Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials Anirban BasuDavid Meltzer Leading Article 27 December 2012 Pages: 859 - 868
New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses Douglas W. MapelMelissa H. Roberts Practical Application Open access 27 December 2012 Pages: 869 - 885
Counting the Cost of Not Costing HIV Health Facilities Accurately Eduard J. BeckCarlos AvilaPaul De Lay Review Article 27 December 2012 Pages: 887 - 902
The Cost Effectiveness of Newer Epilepsy Treatments Kristian BolinLars Forsgren Systematic Review 27 December 2012 Pages: 903 - 923
The State of Health Economic Research in South Africa Paul GavazaKaren L. RascatiStar Khoza Systematic Review 27 December 2012 Pages: 925 - 940
Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting Laura McCullaghCathal WalshMichael Barry Original Research Article 27 December 2012 Pages: 941 - 959
Patient Preferences for Community Pharmacy Asthma Services Pradnya Naik-PanvelkarCarol ArmourBandana Saini Original Research Article 27 December 2012 Pages: 961 - 976
Validity of Cost and Utility Results? Alex DiamantopoulosLaura SawyerNguyen CM Bounthavong Correspondence 27 December 2012 Pages: 977 - 977
The Authors’ Reply Mark BounthavongChristine M. NguyenAnthony P. Morreale Correspondence 27 December 2012 Pages: 977 - 978
Is There a Role for Pharmacoeconomics in Decision Making? Johan C. F. van Luijn Correspondence 27 December 2012 Pages: 979 - 979
The Authors’ Reply Ties HoomansJohan L. SeverensGepke O. Delwel Correspondence 27 December 2012 Pages: 980 - 980